NCT02083926View on ClinicalTrials.gov

Ketamine Infusion for Social Anxiety Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 2, 2015

Primary Completion Date

September 27, 2016

Study Completion Date

September 27, 2016

Conditions
Social Anxiety Disorder
Interventions
DRUG

Ketamine

Ketamine (a single 0.5mg/kg intravenously over 40 minutes).

OTHER

Saline

Saline (a single 0.5mg/kg intravenously over 40 minutes).

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

All Listed Sponsors
collaborator

Patterson Trust Mentored Research Award: Clinical, Health Services and Policy Research

OTHER

lead

Yale University

OTHER

NCT02083926 - Ketamine Infusion for Social Anxiety Disorder | Biotech Hunter | Biotech Hunter